Shenzhen Lifotronic Technology Co., Ltd. Stock
Equities
688389
CNE100005WZ5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.00 CNY | -2.99% |
|
+2.20% | -42.25% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
| Capitalization | 5.57B 785M | P/E ratio 2024 * |
13.4x | P/E ratio 2025 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise value | 9.6B 1.35B | EV / Sales 2024 * |
4.01x | EV / Sales 2025 * | 3.26x |
| Free-Float |
45.76% | Yield 2024 * |
2.54% | Yield 2025 * | 3% |
More valuation ratios
* Estimated data
More news
| 1 day | -2.99% | ||
| 1 week | +2.20% | ||
| Current month | -3.35% | ||
| 1 month | -10.78% | ||
| 3 months | -26.43% | ||
| 6 months | -31.00% | ||
| Current year | -42.25% |
1 week
12.68
13.84
1 month
12.6814.79
Current year
12.6822.70
1 year
12.6825.00
3 years
12.0230.57
5 years
12.0240.96
10 years
12.0240.96
| Director | Title | Age | Since |
|---|---|---|---|
Ming Long Hu
CEO | Chief Executive Officer | 55 | 13-12-31 |
Min Liu
CHM | Chairman | 55 | 07-12-31 |
Hong Wang
DFI | Director of Finance/CFO | 58 | 10-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xian Cheng Liu
FOU | Founder | 56 | 08-01-15 |
Ming Long Hu
CEO | Chief Executive Officer | 55 | 13-12-31 |
Ying Zeng
BRD | Director/Board Member | 55 | 12-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -2.99% | +2.20% | -37.98% | -27.86% | 785M | ||
| -1.45% | -1.63% | +18.71% | -5.24% | 14.41B | ||
| +0.62% | +3.23% | +6.80% | +54.30% | 7.69B | ||
| +1.86% | +6.87% | +67.72% | +319.31% | 7.33B | ||
| -0.38% | +0.34% | +13.90% | -48.35% | 6.15B | ||
| +0.89% | -3.40% | +71.59% | -53.18% | 3.29B | ||
| -0.83% | -4.10% | -17.31% | -22.21% | 3.12B | ||
| -3.80% | -1.37% | -53.41% | -86.55% | 2.7B | ||
| -1.87% | -5.37% | +9.92% | +462.48% | 2.62B | ||
| +1.12% | +2.80% | +63.83% | -14.47% | 2.51B | ||
| Average | -0.68% | +1.16% | +14.38% | +57.82% | 5.06B | |
| Weighted average by Cap. | -0.38% | +2.28% | +21.69% | +60.52% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.39B 196M | 1.71B 241M |
| Net income | 415M 58.48M | 517M 72.93M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,481
Calendar
2024-10-20
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-13 | 13.00 ¥ | -2.99% | 3,245,288 |
| 24-09-12 | 13.40 ¥ | -1.54% | 5,112,112 |
| 24-09-11 | 13.61 ¥ | +5.10% | 9,013,402 |
| 24-09-10 | 12.95 ¥ | +1.33% | 3,528,766 |
| 24-09-09 | 12.78 ¥ | +0.47% | 5,564,499 |
End-of-day quote Shanghai S.E., September 12, 2024
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.00CNY
Average target price
20.87CNY
Spread / Average Target
+60.56%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688389 Stock